ACURA PHARMACEUTICALS INC's ticker is ACUR and the CUSIP is 00509L802. A total of 23 filers reported holding ACURA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $352,000 | +63.7% | 1,956,397 | 0.0% | 0.18% | +103.5% |
| Q4 2018 | $215,000 | -42.2% | 1,956,397 | 0.0% | 0.09% | +11.7% |
| Q3 2018 | $372,000 | -47.2% | 1,956,397 | 0.0% | 0.08% | -52.8% |
| Q2 2018 | $704,000 | -29.5% | 1,956,397 | 0.0% | 0.16% | -25.2% |
| Q1 2018 | $998,000 | +27.5% | 1,956,397 | 0.0% | 0.22% | +53.5% |
| Q4 2017 | $783,000 | -11.0% | 1,956,397 | 0.0% | 0.14% | -9.0% |
| Q3 2017 | $880,000 | -19.7% | 1,956,397 | 0.0% | 0.16% | -21.2% |
| Q2 2017 | $1,096,000 | -6.9% | 1,956,397 | 0.0% | 0.20% | -26.4% |
| Q1 2017 | $1,177,000 | -21.8% | 1,956,397 | 0.0% | 0.27% | -21.6% |
| Q4 2016 | $1,506,000 | -51.9% | 1,956,397 | 0.0% | 0.34% | -47.3% |
| Q3 2016 | $3,130,000 | -13.5% | 1,956,397 | 0.0% | 0.65% | -28.6% |
| Q2 2016 | $3,619,000 | -34.6% | 1,956,397 | 0.0% | 0.91% | -37.1% |
| Q1 2016 | $5,537,000 | +13.2% | 1,956,397 | 0.0% | 1.45% | +62.1% |
| Q4 2015 | $4,891,000 | +6.4% | 1,956,397 | 0.0% | 0.89% | +6.3% |
| Q3 2015 | $4,598,000 | – | 1,956,397 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,956,397 | $3,130,000 | 0.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,025,641 | $1,641,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 352,835 | $565,000 | 0.02% |
| FAS Wealth Partners, Inc. | 16,396 | $26,000 | 0.01% |
| Asset Planning Services, Ltd. | 348 | $1,000 | 0.00% |
| SEI INVESTMENTS CO | 130 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 851 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2 | $0 | 0.00% |
| NORTHERN TRUST CORP | 12,845 | $20,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,045 | $33,000 | 0.00% |